Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Source:http://linkedlifedata.com/resource/pubmed/id/18612313

Download in:

View as

General Info

PMID
18612313